SCHEMBL4565929

SCHEMBL4565929

C[AsH]c1cc2c(cn1)cc(-c1cc(NC(=O)Nc3cnc(C(C)(C)C)o3)c(F)cc1Cl)c(=O)n2C

nearest known ligand 0.38

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
BRAF P15056 5/20 0.38
RAF1 P04049 4/20 0.38
KRAS P01116 3/20 0.36
KDR P35968 3/20 0.36
MAP2K2 P36507 3/20 0.36
MAP2K1 Q02750 3/20 0.36
KIT P10721 1/20 0.34
PDGFRA P16234 1/20 0.34
FGFR1 P11362 6/20 0.33
SRC P12931 5/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5061696 0.88 BRAF (0.47) BRAFRAF1KRASKDRMAP2K2
SCHEMBL5062818 0.82 BRAF (0.58) BRAFRAF1KRASKDRKIT
SCHEMBL5065310 0.80 BRAF (0.57) BRAFRAF1KRASKDRMAP2K2
SCHEMBL5057705 0.79 BRAF (0.51) BRAFRAF1KRASKDRMAP2K2
SCHEMBL4425085 0.75 BRAF (0.63) BRAFRAF1KRASKDRMAP2K2
SCHEMBL5057397 0.73 BRAF (0.48) BRAFRAF1KRASKDRMAP2K2
SCHEMBL4563329 0.73 BRAF (0.69) BRAFRAF1KRASKDRMAP2K2
SCHEMBL22538096 0.72 FGFR1 (0.55) BRAFRAF1KRASKDRMAP2K2
SCHEMBL5065438 0.72 BRAF (0.48) BRAFRAF1KRASKDRMAP2K2
SCHEMBL5057400 0.71 FGFR1 (0.50) BRAFRAF1KRASKDRMAP2K2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2063897-A2 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES Deciphera Pharmaceuticals, LLC. (US) 2009-06-03 EP disclosed
WO-2008034008-A2 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES DECIPHERA PHARMACEUTICALS, LLC. (US) 2008-03-20 WO disclosed